Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J.J., Ponikowski, P., Poole-Wilson, P.A., Stromberg, A., van Veldhuisen, D.J., Atar, D., Hoes, A.W., et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal, 29, 2388-2442. doi:10.1093/eurheartj/ehn309

has been cited by the following article:

• TITLE: Discharge heart rate and future events among Japanese patients with acute heart failure receiving beta-blocker therapy

  AUTHORS: Kazuki Oshima, Shun Kohsaka, Kimi Koide, Yuji Nagatomo, Toshiyuki Nagai, Yutaka Endo, Tsutomu Yoshikawa, Keiichi Fukuda

  KEYWORDS: Heart Failure; Beta-Blocker; Heart Rate; Pharmaceutical Preparations

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.3 No.1A, March 29, 2013

  ABSTRACT: Background: Randomized trials have demonstrated the efficacy of beta-blockers (BBs) in heart failure (HF) patients. We sought to assess the impact of BBs on long-term outcome; in particular, we assessed the association between outcome and BB dose and discharge heart rate. Methods and Results: Prescriptions for dispensed medication and outcomes were identified from a prospective, single-institution HF registry. Long-term prognosis was compared between users and non-users of BBs. BB users were further divided into 2 groups based on dose (full and non-full dose) and discharge heart rate (70 bpm was significantly associated with impaired long-term outcome (HR = 1.872, P = 0.04). Conclusions: Optimizing heart rate, rather than maximizing BB dose, appears to be an appropriate treatment strategy for the beta-sensitive Japanese population.